All Industry articles – Page 15
View all stories with this category.
-
BusinessCelgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
-
Business
Silence Therapeutics and Alnylam in patent dispute
Suit alleges competitors need to license Silence patents relating to their drug cantidates
-
Business
Amplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
-
Business
Ukraine plans to privatise state chemical producers
Government aims to develop struggling industry by attracting foreign investment
-
Opinion
What's holding back continuous manufacturing?
Despite manay advantages, the move to flow chemistry in fine and speciality chemicals is slow
-
-
Business
GM corn growers win US lawsuit against Syngenta
Kansas jury awards over $217m damages to farmers in the first of eight trials
-
News
Cancer committee under siege over glyphosate
US chemical industry group and Monsanto accuse agency of withholding information showing no link between glyphosate and cancer
-
Business
J&J licenses Protagonist’s inflammatory bowel peptide
Potential first-in-class treatment is just about to enter clinical trials
-
Business
Explosion kills 10 at Chinese petrochemical plant
Nine others injured when gas tanker exploded in loading area
-
Business
Ineos expands North Sea oil and gas operations
Purchase of Danish Dong Energy and BP’s Forties pipeline will feed Grangemouth refinery
-
Opinion
Unpicking a clinical trial death
A new study shows up off-target effects of a drug that proved deadly, and highlights the pitfalls of drug discovery
-
Business
US supreme court limits patent rights
Biotech industry is concerned that ruling will hit small companies
-
Business
Dow will face dioxin suit
US appeals court rules property owners have a valid case over soil contamination
-
Business
First biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
Business
Willow promises new medicines
Investigating tree’s metabolites throws up much more than aspirin
-
Opinion
Drug pricing must be more transparent
Pricing is a complex issue - how can we make it clearer?
-
Business
European Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified
-
Business
GE accused of exposing workers to toxic chemicals
Canadian union says dangerous compounds were used without proper worker protection
-
Business
Huntsman and Clariant agree merger deal
Uniting Huntsman’s bulk materials with Clariant’s additives gives a more integrated speciality chemicals offering
